The synergistic effects of RA and a MEK inhibitor in inducing cell death and proliferation arrest encouraged us to inquire whether these two drugs synergistically suppress tumorigenic ability of breast cancer cells. The gene discussed is MAP2K7; the disease is breast carcinoma.